| Bioactivity | Pimivalimab (JTX-4014) is a PD-1 inhibitor. Pimivalimab can be used for the research of solid tumor[1]. |
| Name | Pimivalimab |
| CAS | 2293951-22-9 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. K. Papadopoulos, et al. 172P Phase I study of JTX-8064, a LILRB2 (ILT4) inhibitor, as monotherapy and combination with pimivalimab (pimi), a PD-1 inhibitor (PD-1i), in patients (pts) with advanced solid tumors. VOLUME 16, SUPPLEMENT 1, 100284, DECEMBER 01, 2022. |